[F1 ANNEX U.K. Eligible actions

Textual Amendments

F1 Inserted by Council Regulation (EU) 2020/521 of 14 April 2020 activating the emergency support under Regulation (EU) 2016/369, and amending its provisions taking into account the COVID‐19 outbreak.

The following actions may be financed in case of pandemics with large‐scale effect:

(a)

temporary reinforcement of the medical workforce, exchange of medical professionals, hosting foreign patients or other type of mutual support;

(b)

deployment of temporary healthcare facilities and temporary extension of existing healthcare facilities to relieve pressure on existing structures and increase overall healthcare capacity;

(c)

activities to support the administration of large‐scale application of medical tests and prepare the necessary scientific testing strategies and protocols;

(d)

setting up temporary quarantine facilities and other appropriate measures at the Union borders;

(e)

development, production or purchase and distribution of medical products;

(f)

increases and conversions of production capacities for medical products as referred to in point (e) to address supply shortages;

(g)

maintenance of the stock of medical products as referred to in point (e) and their disposal;

(h)

actions to support the necessary steps to obtain approval for the use of the medical products as referred to in point (e) if required;

(i)

actions to develop appropriate methods to track the development of the pandemic and the results of measures implemented to address it;

(j)

organisation of ad‐hoc clinical trials of potential therapies or diagnostics according to trial standards agreed at Union level;

(k)

scientific validation of medical products, including potential new testing methods.

The above list is not exhaustive.]